Analysis of haploinsufficiency in human neural progenitor cells: insights into early molecular effects of autism-related genes.

Publication date: Jul 08, 2026

Haploinsufficiency describes a phenomenon where one functional allele of a gene in a diploid cell or organism is insufficient for a normal phenotype. There are several neurodevelopmental disorders (NDD) affected by the haploinsufficiency phenomenon, and many of them are related to autism spectrum disorder (ASD). Here, we aim to identify genes involved in the early stages of neural differentiation when one of the two alleles is lost. We thus differentiated a genome-wide heterozygous loss-of-function CRISPR library into neural progenitor cells (NPCs) and defined about 250 genes essential for neural differentiation in a haploinsufficient manner. We were able to identify NDD-related dosage-sensitive pathways and pinpoint specific molecular processes affected by ASD-related genes. By comparing the molecular phenotypes of homozygote and heterozygote mutations, we could illuminate overlapping and distinct transcriptional pathways affected in the two mutant models, along with partial chemical rescue of some of these phenotypes. Our work provides a comprehensive framework for exploring dosage-sensitive regulation in early neural development and offers new insights into the embryonic molecular basis of ASD and other NDDs driven by gene dosage imbalance.

Open Access PDF

Concepts Keywords
Crispr Affected
Genome Asd
Library Autism
Models Differentiation
Neurodevelopmental Dosage
Early
Genes
Haploinsufficiency
Insights
Molecular
Ndd
Neural
Phenomenon
Progenitor
Related

Semantics

Type Source Name
disease MESH autism
disease MESH neurodevelopmental disorders
disease MESH autism spectrum disorder
disease MESH Death
disease MESH Dis
pathway REACTOME Reproduction
disease MESH included
disease MESH image
drug DRUGBANK Neomycin
drug DRUGBANK Trypsin
drug DRUGBANK Edetic Acid
disease MESH infection
drug DRUGBANK Puromycin
disease MESH fed
drug DRUGBANK Amino acids
drug DRUGBANK Streptomycin
drug DRUGBANK Basic Fibroblast Growth Factor
drug DRUGBANK L-Glutamine
drug DRUGBANK Benzylpenicillin
disease MESH NPC
disease MESH Ham
drug DRUGBANK Ascorbic acid
disease MESH STAR
drug DRUGBANK Coenzyme M
drug DRUGBANK Sodium lauryl sulfate
disease MESH SDS
drug DRUGBANK Tromethamine
drug DRUGBANK Methylamine
drug DRUGBANK Urokinase
drug DRUGBANK Pidolic Acid
disease MESH PCA
disease MESH neurodegenerative disease
disease MESH hypotonia
disease MESH seizures
disease MESH spasms
disease MESH ataxia
disease MESH microcephaly
disease MESH cerebellar ataxia
disease MESH ESCs
pathway REACTOME Fertilization
disease MESH syndromes
pathway KEGG Focal adhesion
pathway REACTOME Ion homeostasis
drug DRUGBANK Myricetin
disease MESH NOD
pathway REACTOME Signal Transduction
disease MESH epilepsy
disease MESH PKC
drug DRUGBANK Isoxaflutole
drug DRUGBANK Thymol
disease MESH autosomal dominant
disease MESH macrocephaly
disease MESH intellectual disability
disease MESH Sotos syndrome
disease MESH ADHD
disease MESH muscular dystrophy
disease MESH Gan
pathway REACTOME Neurodegenerative Diseases
disease MESH psychiatric disorders
disease MESH spinal cord injury
disease MESH genetic disorders
disease MESH glioma
pathway KEGG Glioma
disease MESH glioblastoma
disease MESH tumor
drug DRUGBANK Diethylstilbestrol
disease MESH Des
drug DRUGBANK Methionine
drug DRUGBANK Saquinavir
pathway KEGG ErbB signaling pathway
disease MESH Spastic Ataxia
disease MESH Schizophrenia
drug DRUGBANK Creatine
disease MESH EXT1
drug DRUGBANK Cadmium
drug DRUGBANK Copper
pathway KEGG Hedgehog signaling pathway

Original Article

(Visited 37 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *